NFH

Network For Hope - A New Era in Organ Donation Advocacy

Retrieved on: 
Thursday, May 9, 2024

The decision to merge and re-brand as Network for Hope stems from a shared vision of enhancing organ donation advocacy and support services throughout Kentucky, Ohio, Indiana, and West Virginia.

Key Points: 
  • The decision to merge and re-brand as Network for Hope stems from a shared vision of enhancing organ donation advocacy and support services throughout Kentucky, Ohio, Indiana, and West Virginia.
  • By combining forces, the newly formed Network for Hope will be better positioned to serve more donors, their families, and transplant recipients with compassion, efficiency, and innovation.
  • Both KODA and LifeCenter have long-standing legacies of excellence in organ donation advocacy and procurement.
  • Network for Hope (NFH) will be a newly formed organization resulting from the merger between Kentucky Organ Donor Affiliates, Inc. (KODA) and LifeCenter Organ Donor Network (LifeCenter).

My Crew Doses Inc. Announces the No Fallen Heroes Partnership and Addition of Key Strategic Investors and Advisors

Retrieved on: 
Thursday, November 9, 2023

"We've assembled an exceptional dream team composed of highly motivated leaders who are currently excelling in their careers.

Key Points: 
  • "We've assembled an exceptional dream team composed of highly motivated leaders who are currently excelling in their careers.
  • Strategic Advisors and Veteran Support:
    Included on our advisory team is AJA Partners, led by Andrea McLenon, Angie Weber, and Jon Weber.
  • A portion of all sales will be donated to the No Fallen Heroes Foundation, a 501c3 non-profit founded by Buckley.
  • "The No Fallen Heroes Foundation provides healing grants to Veterans, First Responders, and their families who seek to heal with psychedelic-assisted therapy.

Non-Fungible Heroes Celebrates International Day of The Girl by Funding the Future of Females in Web3

Retrieved on: 
Tuesday, October 11, 2022

SAN FRANCISCO, Oct. 11, 2022 /PRNewswire/ -- Non-Fungible Heroes NFT is proud to support the future of women in Web3 by leading a community fundraising effort for Girls Who Code in honor of International Day of The Girl.

Key Points: 
  • SAN FRANCISCO, Oct. 11, 2022 /PRNewswire/ -- Non-Fungible Heroes NFT is proud to support the future of women in Web3 by leading a community fundraising effort for Girls Who Code in honor of International Day of The Girl.
  • "We're thrilled to support such a visionary charity," says Head of Marketing for NFH, MK Bedosky.
  • We know that the biggest drop off of girls in computer science is between the ages of 13 and 17."
  • Non-Fungible Heroes by GenCity Labs is an illustrated collection of Hero, Villain and God characters that are brought to life through games and comics.

New Frontier Health Corporation Announces Completion of Going Private Transaction

Retrieved on: 
Wednesday, January 26, 2022

As a result of the Merger, the Company became a wholly owned subsidiary of Parent and will cease to be a publicly traded company.

Key Points: 
  • As a result of the Merger, the Company became a wholly owned subsidiary of Parent and will cease to be a publicly traded company.
  • Record holders of Shares or Warrants should wait to receive the letters of transmittal before surrendering their Shares or Warrants.
  • New Frontier Health Corporation (NYSE: NFH) is the operator of United Family Healthcare (UFH), a leading private healthcare provider offering comprehensive premium healthcare services in China through a network of private hospitals and affiliated ambulatory clinics.
  • UFH currently has nine hospitals in operation or under construction in all four tier 1 cities and selected tier 2 cities.

New Frontier Health Corporation Receives Notification from NYSE Regarding Delayed Filing of Semi-Annual Financial Information for the Half Year Ended June 30, 2021

Retrieved on: 
Tuesday, January 11, 2022

The NYSE informed the Company that, under the NYSEs rules, the Company has six months from December 31, 2021 to file the 1H 2021 6-K with the SEC (the Automatic Cure Period).

Key Points: 
  • The NYSE informed the Company that, under the NYSEs rules, the Company has six months from December 31, 2021 to file the 1H 2021 6-K with the SEC (the Automatic Cure Period).
  • If the NYSE determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence pursuant to Section 804.00 of the NYSE Listed Company Manual.
  • If the NYSE determines that an Additional Cure Period is appropriate and the Company fails to file the 1H 2021 6-K by the end of that period, suspension and delisting procedures will generally commence.
  • UFH currently has nine hospitals in operation or under construction in all four tier 1 cities and selected tier 2 cities.

New Frontier Health Corporation Announces Shareholders’ Approval of Merger Agreement and Warrantholders’ Approval of Warrant Amendment

Retrieved on: 
Friday, January 7, 2022

Of the ordinary shares voted at the EGM, approximately 99.85% voted in favor of the proposal to authorize and approve the Merger Agreement, the Plan of Merger and the transactions contemplated thereby, including the Merger.

Key Points: 
  • Of the ordinary shares voted at the EGM, approximately 99.85% voted in favor of the proposal to authorize and approve the Merger Agreement, the Plan of Merger and the transactions contemplated thereby, including the Merger.
  • The Company also announced today that it has obtained sufficient consents from warrantholders of the Company to effect the Warrant Amendment (as defined in the Merger Agreement) in connection with the Merger.
  • Upon receipt of such consents, the Company executed the Warrant Amendment with Continental Stock Transfer & Trust Company, the warrant agent.
  • The completion of the Merger is subject to the satisfaction or waiver of the closing conditions set forth in the Merger Agreement.

New Frontier Health Corporation Announces Extraordinary General Meeting of Shareholders and Solicitation for Warrantholder Consent

Retrieved on: 
Thursday, December 2, 2021

In addition, the Companys ordinary shares and warrants would cease to be registered under Section 12 of the Securities Exchange Act of 1934 following the consummation of the Merger.

Key Points: 
  • In addition, the Companys ordinary shares and warrants would cease to be registered under Section 12 of the Securities Exchange Act of 1934 following the consummation of the Merger.
  • Warrantholders of record as of the close of business in the Cayman Islands on December 6, 2021 will be entitled to submit a consent with respect to the Warrant Amendment prior to the Warrantholder Consent Deadline.
  • In addition, the Companys proxy and consent solicitation materials (including the definitive proxy and consent solicitation statement) will be mailed to the shareholders and warrantholders of the Company.
  • UFH currently has nine hospitals in operation or under construction in all four tier 1 cities and selected tier 2 cities.

Vicarious Surgical Business Combination Approved; Stock to Begin Trading on the New York Stock Exchange as “RBOT”

Retrieved on: 
Wednesday, September 15, 2021

Following the close of the transaction, the combined company will be renamed Vicarious Surgical Inc. Its Class A common stock and warrants are expected to begin trading on the New York Stock Exchange (NYSE) on September 20, 2021, under the symbols RBOT and RBOT WS, respectively.

Key Points: 
  • Following the close of the transaction, the combined company will be renamed Vicarious Surgical Inc. Its Class A common stock and warrants are expected to begin trading on the New York Stock Exchange (NYSE) on September 20, 2021, under the symbols RBOT and RBOT WS, respectively.
  • With its disruptive next-generation robotics technology, Vicarious Surgical is seeking to increase the efficiency of surgical procedures, improve patient outcomes, and reduce healthcare costs.
  • Vicarious Surgical believes that the Vicarious System is the first surgical robotic system to receive Breakthrough Device Designation from the U.S. Food and Drug Administration (the FDA)1.
  • We believe Vicarious Surgical is advancing the state of the art, resolving longstanding technical challenges that have limited the capabilities and adoption of surgical robots.

Vicarious Surgical Inc. and D8 Holdings Corp. Announce Additional PIPE Commitments

Retrieved on: 
Friday, September 10, 2021

The additional commitments ensure that D8 will satisfy the closing condition that D8 has at least $125 million of available cash from D8s trust account and proceeds from the PIPE at the closing.

Key Points: 
  • The additional commitments ensure that D8 will satisfy the closing condition that D8 has at least $125 million of available cash from D8s trust account and proceeds from the PIPE at the closing.
  • There may be additional risks that neither Vicarious Surgical nor D8 presently know or that Vicarious Surgical and D8 currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements.
  • Vicarious Surgical and D8 anticipate that subsequent events and developments will cause Vicarious Surgicals and D8s assessments to change.
  • However, while Vicarious Surgical and D8 may elect to update these forward-looking statements at some point in the future, Vicarious Surgical and D8 specifically disclaim any obligation to do so.